Out with the Old and in with the New: Hepatic Fibrosis Assessment in Canada by Natasha Chandok

Get full text

Catamenial Hemoptysis and Pneumothoraces in a Patient with Cystic Fibrosis by Chris M Parker, Robert Nolan, M Diane Lougheed

“…A 32-year-old woman with cystic fibrosis, who over a period of several months had experienced recurrent catamenial hemoptysis and pneumothoraces, including an episode of life-threatening hemoptysis that coincided with menstruation, is presented. …”
Get full text

Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies by Xingpeng Di, Ya Li, Jingwen Wei, Tianyue Li, Banghua Liao

Subjects: Get full text

Machine learning potential predictor of idiopathic pulmonary fibrosis by Chenchun Ding, Quan Liao, Renjie Zuo, Shichao Zhang, Zhenzhen Guo, Junjie He, Ziwei Ye, Weibin Chen, Sunkui Ke

Subjects: “…idiopathic pulmonary fibrosis…”
Get full text

The concentration of calprotectin in the stools of children with diagnosed cystic fibrosis by Sabina Więcek, Halina Woś, Bożena Kordys-Darmolińska, Magda Sankiewicz-Szkółka, Urszula Grzybowska-Chlebowczyk

Subjects: “…cystic fibrosis…”
Get full text

Cepacia Syndrome in a Non-Cystic Fibrosis Patient by Naomi Hauser, Jose Orsini

“…The potential for this pathogen to infect non-cystic fibrosis patients is limited and its epidemiology is poorly understood. …”
Get full text

Protease-activated receptor 1 in the pathogenesis of cystic fibrosis by Sarath Ranganathan, Philip Sutton, Sophie Day, Poshmaal Dhar, Kristy Azzopardi, Muhammad A Saeed, Sohinee Sarkar, Jia-Xi Han

“…Background The most common cause of death in those with cystic fibrosis (CF) is respiratory failure due to bronchiectasis resulting from repeated cycles of respiratory infection and inflammation. …”
Get full text

Effects of nintedanib on circulating biomarkers of idiopathic pulmonary fibrosis by R. Gisli Jenkins, Vincent Cottin, Yasuhiko Nishioka, Imre Noth, Eric S. White, Carina Ittrich, Claudia Diefenbach, Klaus B. Rohr, Moisés Selman, Toby M. Maher

“…Background Biomarkers that change in response to nintedanib in subjects with idiopathic pulmonary fibrosis (IPF) would be valuable. We investigated the effects of nintedanib on circulating biomarkers in subjects with IPF in the INMARK trial. …”
Get full text

Lack of efficacy of tocilizumab in acute exacerbation of pulmonary fibrosis by Giovanni Franco, Pierre Le Guen, Mathilde Le Brun, Quentin Philippot, Clairelyne Dupin, Marie-Pierre Debray, Catherine Bancal, Camille Taillé, Raphaël Borie, Bruno Crestani

Get full text

The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung by Matthew S. Twigg, Simon Brockbank, Philip Lowry, S. Peter FitzGerald, Clifford Taggart, Sinéad Weldon

“…Cystic fibrosis (CF) lung disease is an inherited condition with an incidence rate of approximately 1 in 2500 new born babies. …”
Get full text

Exacerbation of Pulmonary Fibrosis Following Single Lung Transplantation by Dawei Yang, Jennifer M Wilson, Chunxue Bai, John Yee, Pearce G Wilcox, Nasreen Khalil, Robert D Levy

“…Hence, the patient fulfilled the criteria for a diagnosis of an acute exacerbation of pulmonary fibrosis in his native lung. Clinicians should consider acute exacerbation of parenchymal lung disease of the native lung in the differential diagnosis of progressive respiratory deterioration following single lung transplantation for pulmonary fibrosis.…”
Get full text

Cellular senescence in malignant transformation of oral submucous fibrosis! by Satya Ranjan Misra, M. Sathyakumar, Pavitra Baskaran, Rupsa Das

Get full text

The Involvement of Glycosaminoglycans in Airway Disease Associated with Cystic Fibrosis by Emer P. Reeves, David A. Bergin, Michelle A. Murray, Noel G. McElvaney

“…Individuals with cystic fibrosis (CF) present with severe airway destruction and extensive bronchiectasis. …”
Get full text

Mesenchymal Stem Cells in Renal Fibrosis: The Flame of Cytotherapy by Quan Zhuang, Ruoyu Ma, Yanshuang Yin, Tianhao Lan, Meng Yu, Yingzi Ming

“…Based on the mechanism of renal fibrosis, MSCs mostly participate throughout the renal fibrotic process. …”
Get full text

Metformin and Fibrosis: A Review of Existing Evidence and Mechanisms by Maoyan Wu, Huiwen Xu, Jingyu Liu, Xiaozhen Tan, Shengrong Wan, Man Guo, Yang Long, Yong Xu

“…Fibrosis in the lung, kidney, and liver accounts for a substantial proportion of the global burden of disability and mortality. …”
Get full text

Update of Faecal Markers of Inflammation in Children with Cystic Fibrosis by Jung M. Lee, Steven T. Leach, Tamarah Katz, Andrew S. Day, Adam Jaffe, Chee Y. Ooi

Get full text

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis by Argyris Tzouvelekis, Evangelos Bouros, Anastasia Oikonomou, Paschalis Ntolios, George Zacharis, George Kolios, Demosthenes Bouros

“…Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic interstitial lung disease with ineffective treatment. …”
Get full text

Chinese and western medicine treatment of myocardial fibrosis drugs by Yuxi Zhu, Yuxi Zhu, Fangmei Zhang, Zhongcheng Li, Yu Zhou, Yi Shu, Jian Ruan, Guo Chen

Subjects: “…myocardial fibrosis…”
Get full text

Endocytic recycling is central to circadian collagen fibrillogenesis and disrupted in fibrosis by Joan Chang, Adam Pickard, Jeremy A Herrera, Sarah O'Keefe, Richa Garva, Matthew Hartshorn, Anna Hoyle, Lewis Dingle, John Knox, Thomas A Jowitt, Madeleine Coy, Jason Wong, Adam Reid, Yinhui Lu, Cédric Zeltz, Rajamiyer V Venkateswaran, Patrick T Caswell, Stephen High, Donald Gullberg, Karl E Kadler

Subjects: Get full text

Microscopic Polyangiitis with Pulmonary Fibrosis: An Often-Recognized Manifestation of the Disease by Liam M. Clifford, Jamma Li, Christopher J. Renaud, Suran L. Fernando

“…Pulmonary manifestations including pulmonary fibrosis, emphysema, and bronchiectasis are observed in MPA. …”
Get full text